DCM
PAHC icon

Delpha Capital Management’s Phibro Animal Health PAHC Stock Holding History

Delpha Capital Management’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-569
Closed -$19K – 903
2017
Q4 		$19K Buy
+569
New +$20.2K 0.02% 804

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.55B AUM 50.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CRCP
Copper Rock Capital Partners Boston, Massachusetts $296M AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DIA
Denver Investment Advisors Denver, Colorado $1.89B AUM 7.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Delpha Capital Management's PAHC Position: Q1 2018 in Review

Delpha Capital Management sold out of Phibro Animal Health (PAHC) in Q1 2018, closing a stake of 569 shares — an estimated $19K sold.

Delpha Capital Management first reported a position in PAHC in Q4 2017 and held it in 1 quarter. The position peaked at $19K in Q4 2017. 171 funds tracked by Wall St. Rank hold PAHC as of Q1 2018.

  • Delpha Capital Management reported no remaining Phibro Animal Health position as of Q1 2018 after selling out during the quarter.
  • Delpha Capital Management sold 569 Phibro Animal Health shares in Q1 2018, an estimated $19K.
  • Delpha Capital Management first reported a position in Phibro Animal Health in Q4 2017 and held it in 1 quarter.
  • Delpha Capital Management's Phibro Animal Health position peaked at $19K in Q4 2017.
  • 171 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2018.

Based on Delpha Capital Management's 13F filing for Q1 2018, filed 11 May 2018.